_edited.png)
GLP-1 Weight managment
Semaglutide · Tirzepatide
At VIVO, we believe weight management is about more than a number on the scale. Our medical weight management program combines personalized care, nutrition and lifestyle guidance, and prescription treatment options when appropriate.
We offer semaglutide* and tirzepatide, medications that can help eligible patients manage appetite, food intake, and weight as part of a comprehensive weight-management plan. Treatment is prescribed and monitored by a qualified medical provider based on your health history, goals, and individual needs.
Treatment Duration: 30-45 min.
Treatment Area: Subcutaneous Injection Abdomen · Thigh · Upper Arm
Frequently Asked Questions
GLP-1 medications work with hormone pathways involved in appetite and food intake, helping many patients feel fuller and manage hunger more effectively.
Tirzepatide works on both GLP-1 and GIP receptors, while semaglutide works primarily through the GLP-1 receptor. Both are used as part of a broader approach that includes nutrition and physical activity.
Both medications can support weight management, but they work through different hormone pathways.
Semaglutide is a GLP-1 receptor agonist, while tirzepatide activates both GLP-1 and GIP receptors. The medication that may be right for you depends on your health history, goals, response to treatment, and your provider's clinical assessment.
Eligibility depends on your individual health, medical history, medications, and weight-management goals. FDA-approved weight-management indications generally include adults with obesity or adults who are overweight with at least one weight-related health condition, although specific eligibility and treatment decisions are determined by your provider.
There isn't a one-size-fits-all timeline. Your provider will monitor your progress, response, side effects, and goals to determine whether treatment should be continued, adjusted, or changed.
Weight management is an ongoing process, and your treatment plan may evolve as your needs change.
GLP-1 and related medications can cause side effects, particularly gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort. Your provider will review the potential benefits and risks with you before treatment and monitor your response along the way.
Absolutely. Be sure to discuss your complete medical history, current medications and supplements, allergies, and any previous reactions to weight-management medications.
Your provider will determine whether semaglutide or tirzepatide is appropriate for you and review important precautions and contraindications before prescribing.
Medication is only one part of a comprehensive weight-management plan. FDA-approved semaglutide and tirzepatide for chronic weight management are used alongside a reduced-calorie diet and increased physical activity.
At VIVO, we'll focus on sustainable habits and individualized support—not quick fixes.
Your first visit is about getting to know you. Your provider will review your health history, current medications, weight-management goals, and any relevant health factors to determine whether medical weight management is appropriate.
If medication is recommended, you'll receive guidance on how to use it, what to expect, and when you'll return for follow-up.